Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
DuÅ¡ková M and PospÃÅ¡ilová H | The role of non-aromatizable testosterone metabolite in metabolic pathways. | 2011 | Physiol Res | pmid:21114370 |
DeBarber AE et al. | Profiling sterols in cerebrotendinous xanthomatosis: utility of Girard derivatization and high resolution exact mass LC-ESI-MS(n) analysis. | 2011 | J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. | pmid:21168372 |
UhÃa I et al. | Initial step in the catabolism of cholesterol by Mycobacterium smegmatis mc2 155. | 2011 | Environ. Microbiol. | pmid:21208358 |
Martin LJ et al. | The mitochondrial permeability transition pore regulates nitric oxide-mediated apoptosis of neurons induced by target deprivation. | 2011 | J. Neurosci. | pmid:21209222 |
Finelli A et al. | Impact of 5α-reductase inhibitors on men followed by active surveillance for prostate cancer. | 2011 | Eur. Urol. | pmid:21211899 |
Ho CK and Habib FK | Estrogen and androgen signaling in the pathogenesis of BPH. | 2011 | Nat Rev Urol | pmid:21228820 |
Bortolato M et al. | Isolation rearing-induced reduction of brain 5α-reductase expression: relevance to dopaminergic impairments. | 2011 | Neuropharmacology | pmid:21256141 |
Wu YG et al. | Testosterone, not 5α-dihydrotestosterone, stimulates LRH-1 leading to FSH-independent expression of Cyp19 and P450scc in granulosa cells. | 2011 | Mol. Endocrinol. | pmid:21273442 |
Cha EK and Shariat SF | The use of 5α-reductase inhibitors for the prevention and treatment of prostate cancer. | 2011 | Eur. Urol. | pmid:21277077 |
Sato K et al. | Increased muscular dehydroepiandrosterone levels are associated with improved hyperglycemia in obese rats. | 2011 | Am. J. Physiol. Endocrinol. Metab. | pmid:21285401 |